Jennifer K. Litton, MD, MD Anderson Cancer Center, shares Talazoparib – Active in Metastatic Breast Cancer Pathologic Complete Response Rate of 53 at Annual Meeting 2018
Talazoparib – Active in Metastatic Breast Cancer Pathologic Complete Response Rate of 53
